(Q37587675)

21 August 2017

1 reference

title

Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates (English)

1 reference

21 August 2017

author name string

Shereen Nabhani Gebara

series ordinal

1

1 reference

21 August 2017

Hiba Moubayed

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2009

1 reference

American Journal of Health-System Pharmacy

21 August 2017

published in

1 reference

21 August 2017

volume

66

1 reference

21 August 2017

issue

17

1 reference

21 August 2017

page(s)

1541-1547

1 reference

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonates: mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaws associated with cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaw associated with pamidronate therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Factors associated with osteonecrosis of the jaw among bisphosphonate users

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaw and bisphosphonates

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the Jaw Related to Bevacizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Patients receiving intravenous bisphosphonates should avoid invasive dental procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Bisphosphonates and phossy-jaw: breathing new life into an old problem

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080251

31 March 2020

Identifiers

DOI

10.2146/AJHP080251

1 reference

21 August 2017

1 reference